New evidence supports a greater focus on streptococcal skin infections to prevent rheumatic fever
Medical Journal of Australia · 04.08.2025 · 223 (3) · 114-116
DOI: 10.5694/mja2.52708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Australia, online erschienen am 18.06.2025. Verfasst von Michael G Baker und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Otago, Wellington, New Zealand. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Otago, Wellington, New Zealand.
- Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.
- University of Auckland, Auckland, New Zealand.
- Moana Connect, Auckland, New Zealand.
- Starship Child Health, Auckland, New Zealand.
ORCID-Profile: Michael G Baker
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Baker, M. G., Bennett, J., Percival, T., Leversha, A., Gurney, J., & Moreland, N. J. (2025). New evidence supports a greater focus on streptococcal skin infections to prevent rheumatic fever. Medical Journal of Australia, 223(3), 114-116. https://doi.org/10.5694/mja2.52708
Vancouver
Baker MG, Bennett J, Percival T, Leversha A, Gurney J, Moreland NJ. New evidence supports a greater focus on streptococcal skin infections to prevent rheumatic fever. Medical Journal of Australia. 2025;223(3):114-116. doi:10.5694/mja2.52708
BibTeX
@article{Baker2025,
author = {Baker, Michael G and Bennett, Julie and Percival, Teuila and Leversha, Alison and Gurney, Jason and Moreland, Nicole J},
title = {New evidence supports a greater focus on streptococcal skin infections to prevent rheumatic fever},
journal = {Medical Journal of Australia},
year = {2025},
volume = {223},
number = {3},
pages = {114--116},
doi = {10.5694/mja2.52708}
}
EUVIMED